Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2000
11/02/2000WO2000065042A1 P element derived vector and methods for its use
11/02/2000WO2000065038A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000WO2000065035A1 Telophase enucleated oocytes for nuclear transfer
11/02/2000WO2000065031A1 Human cell line showing stable expression of cytochromes p450
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000065025A2 Dna molecules encoding human endothelin converting enzyme 3
11/02/2000WO2000064954A1 Polymeric encapsulation system promoting angiogenesis
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
11/02/2000WO2000064459A1 Cell therapy for chronic stroke
11/02/2000WO2000064458A2 Method for inducing a donor tolerance in the human body
11/02/2000WO2000064377A1 Prosthetic grafts
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000040739B1 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000037642A9 Method of enhancing the biological activity of ligands
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
11/02/2000WO2000026417A9 Detection of negative-strand rna viruses
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase
11/02/2000WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
11/02/2000WO2000000624A9 Production of urokinase in plant-based expression systems
11/02/2000WO1998042851A8 Plants with modified growth
11/02/2000EP1048736A1 DNA-construct for the tissue specific expression of a blood coagulation factor
11/02/2000EP1048735A1 DNA-construct for the tissue-specific expression of a blood coagulation factor
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048731A2 Method for cloning and producing the SwaI restriction endonuclease
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048724A1 Human myoblast cell lines and their uses
11/02/2000EP1048298A2 Mixed chimerism and tolerance
11/02/2000EP1047937A1 Screening method for apoptosis and necrosis
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047790A1 Root-specific promoter
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047785A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure
11/02/2000EP1047783A1 Gene associated with disease resistance in plants
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047780A1 Orphan receptors
11/02/2000EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047775A1 Hematopoietic signaling factor
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047710A2 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
11/02/2000EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP0790059A4 Means for treating auto-immune diseases and method of treatment
11/02/2000EP0683816B1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19919242A1 Modulare Zellträgersysteme für dreidimensionales Zellwachstum Modular cell carrier systems for three-dimensional cell growth
11/02/2000CA2406572A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371253A1 Genome sequence and polypepides of pyrococcus abissy, fragment and uses thereof
11/02/2000CA2371220A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
11/02/2000CA2371017A1 Cell therapy for chronic stroke
11/02/2000CA2371006A1 Protein-protein interactions
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370541A1 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000CA2370467A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof
11/02/2000CA2370442A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity
11/02/2000CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000CA2370385A1 Telophase enucleated oocytes for nuclear transfer
11/02/2000CA2370365A1 Human cell line showing stable expression of cytochromes p450
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369058A1 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000CA2368253A1 Prosthetic grafts
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367954A1 Dna molecules encoding human endothelin converting enzyme 3
11/01/2000CN1272137A Protease variants and compositions
11/01/2000CN1272136A Stimulation of hematopoietic cells in vitro
11/01/2000CN1058054C Process for producing taxane diterpene and method of harvesting cultred cell capable of producing taxane diterpene in high yield
10/2000
10/31/2000US6140554 Specificity of gene expression
10/31/2000US6140553 Incubating culture of monocotyledonous plant cells on medium including plant phenolic compound to stimulate cell division and enhance competence, then contacting with dna fragment for transformation and stable insertion into the genome
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140486 Isolated nucleic acid having a defined nucleotide sequence from vibrio marinus; for production docosahexanoic acid in transgenic plants; nutrients; dietetics
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140128 Mixing calcium divalent cation, phosphate multivalent anion and the desired nucleic acid to form precipitation mixture, then incubating for 10 to 60 minutes to form particles
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140122 Kits containing compositions which can be used as internal controls in order to control the different stages of the process, particularly to control the contents of monocytes and other constituents of the starting composition
10/31/2000US6140121 Contacting sample containing sperm with solution comprising hexuronic acid monomer or with solution comprising polymer comprising hexuronic acid and arabinose or galactose to form a mixture, separating sperm
10/31/2000US6140119 Expression of estrogen receptors in type I and type II human breast epithelial cells
10/31/2000US6140118 Avian blastodermal cell lines
10/31/2000US6140117 Ninjurin
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140111 Nucleotide sequences utilized for the treatment of genetic disorders in human and animal somatic cells
10/31/2000US6140103 Regulated protein expression in stably transfected mammalian cells